Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Loading…

Medicines
Canada
Trastuzumab deruxtecan

Health Canada 2021

Trastuzumab deruxtecan

Enhertu

100 MG / VIAL Powder For SolutionCanadaMarketedAuthorised 9 Jul 2021

Open in the registerAsk Osler about it

On this page

In other countries
Documents
Sources and licences

In other countries

The same active substances on other registers, the same brand first.

EnhertuBrazil · Daiichi Sankyo Brasil Farmacêutica LtdaSame brand
Enhertu 100 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 107 mg · polvo para concentrado para solución para perfusión · Daiichi Sankyo Europe GmbhSame brand
Enhertu 100 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 107 mg · polvo para concentrado para solución para perfusión · Daiichi Sankyo Europe GmbhSame brand
Enhertu 100 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 107 mg · polvo para concentrado para solución para perfusión · Daiichi Sankyo Europe GmbhSame brand
EnhertuEuropean Union · Daiichi Sankyo Europe GmbHSame brand
EnhertuCroatiaSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

🇮🇹EnhertuItaly · Polvere per concentrato per soluzione per infusione · Abacus Medicine A/SSame brand

🇮🇹EnhertuItaly · Polvere per concentrato per soluzione per infusione · Daiichi Sankyo Europe GMBHSame brand

🇮🇹EnhertuItaly · Polvere per concentrato per soluzione per infusione · New Pharmashop S.R.L.Same brand

🇳🇱Enhertu 100 mg, poeder voor concentraat voor oplossing voor infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · Daiichi Sankyo Europe GmbHSame brand

🇳🇿EnhertuNew Zealand · Inj 100 mg per ml, 1 ml vialSame brand

🇷🇸Enhertu®Serbia · 100mg · prašak za koncentrat za rastvor za infuziju · PredstavniŠTvo Astrazeneca UK Limited BeogradSame brand

🇷🇸Enhertu®Serbia · 100mg · prašak za koncentrat za rastvor za infuziju · PredstavniŠTvo Astrazeneca UK Limited BeogradSame brand

🇸🇬Enhertu Powder for Concentrate for Solution for Infusion 100MG/VialSingapore · 100 mg/vial · infusion, solution concentrate · Astrazeneca Singapore Pte LTDSame brand

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Trastuzumab deruxtecan
Strength: 100 MG / VIAL
Dosage form: Powder For Solution
Route: Intravenous
Register: Canada (Health Canada)
Status: Marketed
Authorised: 9 Jul 2021
Registration: DIN 02514400
Marketing authorisation holder: Astrazeneca Canada INC
ATC code: L01FD04
Group: Antineoplastic and immunomodulating agents
Supply: PRESCRIPTION, SCHEDULE D